Net Cash Provided by (Used in) Operating Activities of Kuvatris Therapeutics, Inc. from 31 Dec 2021 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Kuvatris Therapeutics, Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2021 to 31 Mar 2024.
  • Kuvatris Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2024 was $3,068,471, a 2.9% decline year-over-year.
  • Kuvatris Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $10,768,504, a 77% decline from 2022.
  • Kuvatris Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $6,071,183, a 10% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

Kuvatris Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $3,068,471 -$85,126 -2.9% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q1 2023 $2,983,345 -$2,588,641 -656% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $394,704 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1

Kuvatris Therapeutics, Inc. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $10,768,504 -$4,697,321 -77% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2024 2023 FY
2022 $6,071,183 -$558,544 -10% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
2021 $5,512,639 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.